We also observed a significantly higher percentage of PRL-3 positive tumor cells in patients who had lymph node metastases (regional disease) at the time of diagnosis (n = 48, 66%) as compared with patients whose nodes were tumor free (n = 69, 45%; p = 0.024). Here, PTP4A3 is linked to neoplasm.